Advertisement
U.S. markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
126.59-1.32 (-1.03%)
At close: 04:00PM EST
128.41 +1.82 (+1.44%)
After hours: 07:12PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close127.91
Open127.91
Bid126.45 x 500
Ask136.85 x 100
Day's Range125.43 - 128.27
52 Week Range110.95 - 157.98
Volume739,665
Avg. Volume989,615
Market Cap12.817B
Beta (5Y Monthly)0.35
PE Ratio (TTM)34.12
EPS (TTM)3.71
Earnings DateFeb 05, 2025 - Feb 10, 2025
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 29, 1995
1y Target Est163.46
  • PR Newswire

    Neurocrine Biosciences to Participate at Investor Conferences in December

    Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in December. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at:

  • Simply Wall St.

    High Growth Tech Stocks Featuring Three Prominent US Companies

    Over the last 7 days, the United States market has risen 5.7%, contributing to a remarkable 37% increase over the past year, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable market conditions.